← brief for 2026-09-24 · Slowing decline

The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia?

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looks at diabetes drugs and anemia. It found that some people on these drugs may get low red blood cell counts. The review cites observational data that show this link. This is a strong summary of the evidence for this side effect.

Who did this work

Mizdrak M · Batistić D · Mizdrak I

Source

Paper · PubMed, the drug frontier · 2026 Sep 17
https://pubmed.ncbi.nlm.nih.gov/42783450/